The association between neck adiposity and long-term outcome.
Adiposity
/ physiology
Aged
Anthropometry
/ methods
Cardiovascular Diseases
/ etiology
Computed Tomography Angiography
Diabetes Mellitus
/ etiology
Feasibility Studies
Female
Follow-Up Studies
Humans
Israel
/ epidemiology
Male
Middle Aged
Neck
/ diagnostic imaging
Obesity
/ complications
Retrospective Studies
Risk Assessment
/ methods
Risk Factors
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
02
11
2018
accepted:
03
04
2019
entrez:
24
4
2019
pubmed:
24
4
2019
medline:
15
2
2020
Statut:
epublish
Résumé
Anthropometric indices of obesity (e.g. body mass index, waist circumference and neck circumference) are associated with poor long-term cardiovascular outcome. Prior studies have associated neck circumference and central body adiposity. We explored the association between neck fat volume (NFV) and long-term cardiovascular outcome. The study provides a retrospective analysis of all patients undergoing computerized tomography angiography for suspected cerebrovascular accident between January and December 2013. NFV was assessed by three dimensional reconstructions and was adjusted to height to account for differences in body sizes, thus yielding the NFV/height ratio (NHR). Univariate and multivariate analysis were utilized to explore the association between various indices including NHR and all-cause mortality. The analysis included 302 patients. The average age was 61.9±14.3 years, 60.6% of male gender. Diabetes mellitus, hypertension and cardiovascular disease were frequent in 31.5%, 69.9%, and 72.2% of patients, respectively. The median NHR was 492.53cm2 [IQR 393.93-607.82]. Median follow up time was 41.2 months, during which 40 patients (13.2%) died. Multivariate analysis adjusting for age, sex, and diabetes mellitus indicated an independent association between the upper quartile of NHR and all-cause mortality (hazard ratio = 2.279; 95% CI = 1.209-4.299; p = .011). NHR is a readily available anthropometric index which significantly correlated with poor long-term outcome. Following validation in larger scale studies, this index may serve a risk stratifying tool for cardiovascular disease and future outcome.
Identifiants
pubmed: 31013323
doi: 10.1371/journal.pone.0215538
pii: PONE-D-18-31658
pmc: PMC6478301
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0215538Déclaration de conflit d'intérêts
HSM is the owner of Visionary Corp., in Toronto, Canada, and MMK is affiliated with this organization. Visionary Corp received a grant from NVIDIA Corporation, but had no influence in the current study. The authors' affiliation with Visionary Corp is completely independent of the current study. HSM, MMK, and ST have a patent pending related to another study conducted at the same institution; this is completely independent of and had no influence over the current study. These do not alter the authors' adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.
Références
Circulation. 2007 Dec 18;116(25):2933-43
pubmed: 18071080
Eur J Cardiovasc Prev Rehabil. 2007 Dec;14(6):740-5
pubmed: 18043293
Circulation. 2014 Jun 24;129(25 Suppl 2):S102-38
pubmed: 24222017
Clin Endocrinol (Oxf). 2013 Jun;78(6):874-81
pubmed: 22804918
Int J Obes Relat Metab Disord. 2000 Jan;24(1):33-7
pubmed: 10702748
Diabetes Metab Res Rev. 2013 Jan;29(1):90-7
pubmed: 23135790
Obes Res. 1995 Jan;3(1):9-22
pubmed: 7712364
Lancet. 2005 Nov 5;366(9497):1640-9
pubmed: 16271645
Circulation. 2007 Jul 3;116(1):39-48
pubmed: 17576866
Diabetes Care. 2013 Jan;36(1):e3
pubmed: 23264305
Obesity (Silver Spring). 2012 Jan;20(1):76-87
pubmed: 21660078
Exp Clin Cardiol. 2006 Spring;11(1):14-20
pubmed: 18651013
Clin Nutr. 2009 Feb;28(1):46-51
pubmed: 19010573
Lipids Health Dis. 2016 Mar 05;15:46
pubmed: 26946432
Kidney Int. 2018 Mar;93(3):691-699
pubmed: 29290310
BMJ. 1995 Nov 25;311(7017):1401-5
pubmed: 8520275
J Clin Endocrinol Metab. 2010 Aug;95(8):3701-10
pubmed: 20484490
Obesity (Silver Spring). 2006 Feb;14(2):336-41
pubmed: 16571861
Obesity (Silver Spring). 2013 Sep;21(9):E439-47
pubmed: 23687099
J Intern Med. 2003 Dec;254(6):555-63
pubmed: 14641796
Am J Nephrol. 2017;46(3):239-248
pubmed: 28881341
Annu Rev Nutr. 1997;17:127-39
pubmed: 9240922
Int J Obes (Lond). 2014 Jul;38(7):995-9
pubmed: 24662695
Obes Res. 1997 Nov;5(6):519-30
pubmed: 9449135
Ann Fam Med. 2016 May;14(3):262-6
pubmed: 27184997
Am J Clin Nutr. 2006 Aug;84(2):449-60
pubmed: 16895897
Am J Surg. 2018 Mar;215(3):503-506
pubmed: 29277239
Am J Clin Nutr. 2014 Nov;100(5):1244-51
pubmed: 25332322
J Acquir Immune Defic Syndr. 2007 Nov 1;46(3):283-90
pubmed: 18167644
Int J Obes Relat Metab Disord. 1992 Jun;16(6):417-23
pubmed: 1322867
Medicine (Baltimore). 2015 Nov;94(45):e1991
pubmed: 26559286